Abstract
Excitatory amino acid antagonists arc of two main types: 1) structural analogues of dicarboxylic amino acids that compete with glutamate or other agonists at the receptor site and 2) lipophilic compounds, without acidic groups, that block the excitatory action of agonists by a noncompetitive mechanism. The postsynaptic receptors at which amino acids exert an excitatory action can be classified according to their preferred agonists as kainate-, quisqualate-, and N-methyl-D-aspartate-preferring receptors [1, 2]. Referring to these receptor subtypes as kainate, quisqualate, and NMDA receptors is a convenient shorthand; it implies nothing about the nature of the endogenous neurotransmitters. Glutamate is a highly effective agonist at all three receptor subtypes. Aspartate acts preferentially on the NMDA receptor in spinal cord neurons [3]. The sulphur-containing analogues of glutamate and aspartate interact with quisqualate and NMDA receptors but not with kainate receptors [4].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Davies, J., Evans, R.H., Smith, D.A. and Watkins, J.C. (1982). Differential activation and blockade of excitatory amino acid receptors in the mammalian and amphibian spinal cord. Comp. Biochem. Physiol. 72C, 211–224.
Foster, A.C. and Fagg, G.E. (1984). Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res. Rev. 7, 103–164.
Mayer, M.L. and Westbrook, G.L. (1986). The physiology of excitatory amino acids in the vertebrate central nervous system. Progress in Neurobiology, 28, 197–276.
Murphy, D.E. and Williams, M. (1986). Interaction of sulfur-containing amino acids with quisqualate and kainate excitatory amino acid receptors in rat brain. In Excitatory Amino Acid Transmission, Hicks, T.P., Lodge, D. and McLennan, H., eds., Alan R. Liss, New York, pp. 63–66.
Peet, M.J., Curry, K., Magnuson, D.S. and McLennan, H. (1986). Conformational requirements for activation of burst firing of rat CA-1 hippocampal pyramidal neurones. In Excitatory Amino Acid Transmission. Hicks, T.P., Lodge, D. and McLennan, H., eds., Alan R. Liss, New York, pp. 35–42.
Berry, S.C., Dawkins, S.L. and Lodge, D. (1984). Comparison of o- and K-opiate receptor ligands as excitatory amino acid antagonists. Brit. J. Pharmacol. 83, 179–185.
Lodge, D., Berry, S.C., Church, J., Martin, D., McGhee, A., Lai, H.M. and Thomson, A.M. (1984). Isomers of cyclazocine act as excitatory amino acid antagonists. Neuropeptides 5, 245–248.
Wong, E.H., Kemp, J.A., Priestley, T., Knight, A.R., Woodruff, G.N. and Iversen, L.L. (1986). The novel anticonvulsant MK 801 is a potent N-methyl-D-aspartate antagonist. Proc. Nat. Acad. Sei. USA 83, 7104–7108.
Croucher, M.J., Collins, J. F. and Meldrum, B.S. (1982). Anticonvulsant action of excitatory amino acid antagonists. Science 216, 899–901.
Czuczwar, S.J. and Meldrum, B.S. (1982). Protection against chemically-induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur. J. Pharmacol. 83, 335–338.
Czuczwar, S.J., Cavalheiro, E.A., Turski, L., Turski, W.A. and Kleinrok, Z. (1985). Phos-phonic analogues of excitatory amino acids raise the threshold for maximal electroconvulsions in mice. Neurosci. Res. 3, 86–90.
Meldrum, B.S., Croucher, M.J., Badman, G. and Collins, J.F. (1983). Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio. Neurosci. Lett. 39, 101–104.
Meldrum, B.S., Croucher, M.J., Czuczwar, S.J., Collins, J.F. Curry, K., Joseph, M. and Stone, T.W. (1983). A comparison of the anticonvulsant potency of +-2-amino-5-phos-phonopentanoic acid and (+-)2-amino-7-phosphonoheptanoic acid. Neuroscience 9, 925–930.
Meldrum, B.S., Wardley-Smith, B., Halsey, M. and Rostain, J.C. (1983). 2-amino-7- phosphonoheptanoic acid protects against the high pressure neurological syndrome. Eur. J. Pharmacol. 87, 501–502.
Peterson, D.W., Collins, J.F. and Bradford, H.F. (1984). Anticonvulsant action of amino acid antagonists against kindled hippocampal seizures. Brain Res. 311, 176–180.
Morris, R.G., Anderson, E., Lynch, G.S. and Baudry, M. (1986). Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774–776.
Millan, M.H., Faingold, C.L. and Meldrum, B.S. (1987). Intranigral 2-amino-7-phosphono-heptanoic acid protects against audiogenic seizures in genetically-epilepsy prone rats. In Advances in Epileptology 15, Wolf, P., ed., Raven Press, New York.
Patel, S., Millan, M.H., Mello, L.M. and Meldrum, B.S. (1986).2-amino-7-phosphono-heptanoic acid (2-APH) infusion into entopeduncular nucleus protects against limbic seizures in rats. Neurosci. Lett. 64, 226–230.
Turski, L., Cavalheiro, E.A., Turski, W.A. and Meldrum, B.S. (1986). Excitatory transmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: Effects of intranigral 2-amino-7-phosphonoheptanoate and N-methyl-D-aspartate. Neuroscience 18, 61–67.
Turski, L., Schwarz, M., Turski, W.A., Klockgether, T., Sontag, K-H. and Collins, J.F. (1985). Muscle relaxant action of excitatory amino acid antagonists. Neurosci. Lett. 53, 321–326.
Bennett, D.A. and Amrick, C.L. (1986). Antagonists of N-methyl-D-aspartate (NMDA) produce anticonflict activity. In Excitatory Amino Acid Transmission. Hicks, T.P., Lodge, D. and McLennan, H., eds., Alan R. Liss, New York, pp. 213–216.
Clineschmidt, B.V., Williams, M., Witoslawski, J.J., Bunting, P.R., Risley, E.A. and Totaro, J. A. (1982). Restoration of shock-suppressed behavior by treatment with (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK 801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic properties. Drug Develop. Res. 2, 147–163.
Stephens, D.N., Meldrum, B.S., Weidmann, R., Schneider, C. and Grutzner, M. (1986). Does the excitatory amino acid receptor antagonist 2-APH exhibit anxiolytic activity? Psychopharmacology 90, 166–169.
Collingridge, G.L., Kehl, S.J. and McLennan, H. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol. 334, 33–46.
Harris, E.W. and Cotman, C.W. (1986). Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl-D-aspartate antagonists. Brain Res.
Stringer, J.L. and Guynet, P.E. (1983). Elimination of long-term potentiation in the hippocampus by phencyclidine and ketamine. Brain Res. 258, 159–164.
Halliwell, R.F. and Morris, R.G. (1987). Anticonvulsant doses of MK 801 fail to block long-term potentiation in vivo or impair spatial memory in the rat. Abstracts, Brain Res. Assoc. March, 1987.
Garthwaite, G. and Garthwaite J. (1984). Differential sensitivity of rat cerebellar cells in vitro to the neurotoxic effects of excitatory amino acid analogues. Neurosci. Lett. 48, 361–367.
Garthwaite, G. and Garthwaite, J. (1986). Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration. Neurosci. Lett. 66, 193–198.
Schwarcz, R., Collins, J.F. and Parks, D.A. (1982). α-amino-ω-phosphonocarboxylates block ibotenate but not kainate neurotoxicity in rat hippocampus. Neurosci. Lett. 33, 85–90.
Meldrum, B.S. (1983). Metabolic factors during prolonged seizures and their relation to nerve cell death. In Advances in Neurology 34, Status Epilepticus. Delgado-Escueta, A. V., Wasterlain, C.G., Treiman, D.M. and Porter, R.J., eds., Raven Press, New York, pp. 261–275.
Olney, J.W. (1985). Excitatory transmitters and epilepsy-related brain damage. Int. Rev. Neurobiol. 27, 338–362.
Evans, M.C., Griffiths, T. and Meldrum, B.S. (1984). Kainic acid seizures and the reversibility of calcium loading in vulnerable neurons in the hippocampus. Neuropathol. Appl. Neurobiol. 10, 285–302.
Griffiths, T., Evans, M.C. and Meldrum, B.S. (1983). Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L-allylglycine. Neuroscience 10, 385–395.
Griffiths, T., Evans, M.C. and Meldrum, B.S. (1984). Status epilepticus: The reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus. Neuroscience 12, 557–567.
Sloviter, R.S. and Dempster, D.W. (1985). “Epileptic” brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res. Bull. 15, 39–60.
Simon, R.P., Griffiths, T., Evans, M.C., Swan, J.H. and Meldrum, B.S. (1984). Calcium overload in selectively vulnerable neurons of the hippocampus during and after ischaemia: An electron microscopy study in the rat. J. Cereb. Blood Flow Metab. 4, 350–361.
Johansen, F.F., Jorgensen, M.B. and Diemer, N.H. (1986). Ischemia induced delayed neuronal death in the CA1 hippocampus is dependent on intact glutamatergic innervation. In Excitatory Amino Acid Transmission, Hicks, T.P., Lodge, D. and McLennan, H., eds. Alan R. Liss, pp. 245–248.
Simon, R.P., Swan, J.H., Griffiths, T. and Meldrum, B.S. (1984). Blockade of N-methyl-D-aspartate receptors may protect against ischaemic damage in the brain. Science 226, 850–852.
Evans, M.C, Swan, J.H. and Meldrum, B.S. (1987). Blockade of excitatory neurotransmission provides partial long-term protection against ischaemic brain damage. In Fifteenth Princeton Conference on Cerebrovascular Disease. Raichle, M.E. and Parks, W.S., eds., Raven Press, New York, 27–36.
Boast, C.A., Gerhardt, S.C. and Janak, P. (1986). Systemic AP7 reduces ischaemic brain damage in gerbils. In Excitatory Amino Acid Transmission, edited by Hicks, T.P., Lodge, D. and McLennan, H., eds., Alan R. Liss, New York, pp. 249–252.
Simon, R.P., Meldrum, B.S., Schmidley, J.W., Swan, J.H. and Chapman, A.G. (1987). Mechanisms of selective vulnerability: Hypoglycaemia. In Fifteenth Princeton Conference on Cerebrovascular Diseases, Raichle, M.E. and Parks, W.S. eds., Raven Press, New York, 27–36.
Westerberg, E. and Wieloch, T. (1986). Excitatory amino acids and hypoglycaemic brain damage. In Excitatory Amino Acid Transmission, Hicks, T.P., Lodge, D. and McLennan, H., eds., Alan. R. Liss, New York, pp. 225–232.
Spencer, P.S., Roy, D.N., Ludolph, A., Hugun, J., Dwived, M.P. and Schaumburg, H.H. (1986). Lathyrism: Evidence for role of the neuroexcitatory amino acid BOAA. Lancet II, 1066–1067.
Watkins, J.C., Curtis, D.R. and Biscoe, T.J. (1966). Central effects of B-N-oxalyl-a,e-diaminopropionic acid and other lathyrus factors. Nature 211, 637.
Mouritzen Dam, A. (1979). The density of neurons in the human hippocampus. Neuropathol. Appl. Neurobiol. 5, 249–264.
Ellison, D.W., Beal, M.F., Mazurek, M.F., Bird, E.D. and Martin, J.B. (1986). A postmortem study of amino acid neurotransmitters in Alzheimer’s disease. Ann. Neurol. 20, 616–621.
Quirion, R., DiMaggio, D.A., French, E.D., Contreras P.C., Shiloach, J., Pert, C.B., Everist H., Pert, A. and O’Donohue, T.L. (1984). Evidence for an endogenous peptide ligand for the phencyclidine receptor. Peptides 5, 967–973.
Nishikawa, T., Takashima., M. and Toru, M. (1963). Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci. Lett. 40, 245–250.
Greenamyre, J.T., Penney, J.B., D’Amato, C.J. and Young, A.B. (1987). Dementia of the Alzheimer’s type: Changes in hippocampal L-[3H]glutamate binding. J. Neurochem. 48, 543–551.
Geddes, J.W., Chang-Chui, H., Cooper, S.M. Lott, I.T. and Cotman, C.W. (1986). Density and distribution of NMDA receptors in the human hippocampus in Alzheimer’s disease. Brain Res. 399, 156–161.
Geddes, J.W., Monaghan, D.T., Cotman, C.W., Lott, LT., Kim, R.C. and Chui, H.C. (1985). Plasticity of hippocampal circuitry in Alzheimer’s disease. Science 230, 1179–1181.
Hyman, B.T., VanHoesen, G.W., Damasio, A.R. and Barnes, C.L. (1984). Alzheimer’s disease: Cell specific pathology isolates the hippocampal formation. Science 225, 1168–1170.
Hyman, B.T., VanHoesen, G.W., Kromer, L.J., and Damasio, A.R. (1986). Perforant pathway changes and the memory impairment of Alzheimer’s disease. Ann. Neurol. 20, 472–481.
Greenamyre, J.T., Penney, J.B. and Young, A.B. (1987). Evidence for transient, perinatal glutamatergic innervation of globus pallidus. J. Neurosci. 7, 1022–1030.
Beal, M.F., Kowall, N.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J. and Martin, J.B. (1986). Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid. Nature 321, 168–171.
Koh, J-Y., Peters, S., Choi, D.W. (1986). Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity. Science, 234, 73–76.
Plaitakis A.A., Berl, S. and Yahr, M.D. (1982). Abnormal glutamate metabolism in an adult-onset degenerative neurological disorder. Science 216, 193–196.
Sorbi, S., Tonini, S., Giannini, E., Piacentini, S., Marini, P. and Amadulu, L. (1986). Abnormal platelet glutamate dehydrogenase activity and activation in dominant and non-dominant olivopontocerebellar atrophy. Ann. Neurol. 19, 239–245.
Kornhuber, H.H. (1983). Chemistry, physiology and neuropsychology of schizophrenia: Towards an earlier diagnosis of schizophrenia. I. Arch. Psychiatr. Nervenkr. 233, 415–422.
Kim, J.S., Kornhuber, H.H., Scmid-Burgk, W. and Holzmuller, B. (1980). Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20, 379–382.
Gattaz, W.F., Gattaz, D. and Beckmann, H. (1982). Glutamate in schizophrenics and healthy controls. Arch. Psychiatr. Nervenkr. 231. 221–225.
Perry, T.L. (1982). Normal cerebrospinal fluid and brain glutamate levels in schizophrenia do not support the hypothesis of glutamatergic neuronal dysfunction. Neurosci. Lett. 28, 81–85.
Sherman, A.D. and Mott, J. (1984). Direct effect of neuroleptics on glutamate release. Neuropharmacology 23, 1253–1259.
Sherman, A.D. and Mott, J. (1986). Effects of glutamine inhibition on release of endogenous glutamic acid. Neuropharmacology 25, 1353.
Rudolph, M.I. and Bustos, G. (1986). Search of a L-glutamate receptor related to modulation of neurotransmission in the rat corpus striatum. Neurochem. Int. 8, 481–492.
Cheramy, A., Romo, R., Godehu, G., Baruch, P. and Glowinski, J. (1986). In vivo presynaptic control of dopamine release in the cat caudate nucleus. II. Facilitatory or inhibitory influence of L-glutamate. Neuroscience 19, 1081–1090.
Contreras, P.C., DiMaggio, D.A. and O’Donohue, T.L. (1987). An endogenous ligand for the sigma opiod binding site. Synapse 1, 57–61.
Troupin, A.S., Mending, J.R., Cheng, F. and Risinger, M.W. (1986). MK 801. In New Anticonvulsant Drugs, Meldrum, B.S. and Porter, R.J., eds., John Libbey, London, pp. 191–202.
Croucher, M.J., Meldrum, B.S., Jones, A.W. and Watkins, J.C. (1984). γ-D-glutamyl-aminomethylsulphonic acid (GAMS), a kainate and quisqualate antagonist, prevents sound-induced seizures in DBA/2 mice. Brain Res. 322, 111–114.
Croucher, M.J., Meldrum, B.S. and Collins, J.F. (1984). Anticonvulsant and proconvulsant properties of a series of structural isomers of piperidine dicarboxylic acid. Neuropharmacology 23, 467–472.
Meldrum, B.S., Chapman, A.G. and Mello, L. (1987). Anticonvulsant action of kynurenic acid in reflex epilepsy in DBA/2 mice and in photosensitive baboons. Bender, D. and Joseph, M.H., eds., Progress in Tryptophan and Serotonin Research 1986. Walter de Gruyter & Co. Berlin, pp. 119–126.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Meldrum, B.S. (1988). Pharmacology of Excitatory Amino Acid Antagonists and their Possible Therapeutic Use in Neurological Disease. In: Ferrendelli, J.A., Collins, R.C., Johnson, E.M. (eds) Neurobiology of Amino Acids, Peptides and Trophic Factors. Topics in the Neurosciences, vol 8. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1721-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1721-0_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8969-2
Online ISBN: 978-1-4613-1721-0
eBook Packages: Springer Book Archive